Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT04758767
Title CID-103 (Anti-CD38 Antibody) in Previously Treated Relapsed or Refractory Multiple Myeloma
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors CASI Pharmaceuticals, Inc.
Age Groups: senior | adult
Covered Countries GBR | FRA

Facility Status City State Zip Country Details
CHU de Nantes - Hôpital Hôtel-Dieu Nantes France Details
CHU Rennes - Pontchaillou Rennes France Details
Gustave Roussy Cancer Center Villejuif Cedex France Details
Sarah Cannon London United Kingdom Details
*Shaded cells indicate that there was no data available from for the field